What is the appropriate evaluation and management for a patient with an adrenal mass, hyponatremia, and findings on chest CT?

Evaluation and Management of Adrenal Mass with Hyponatremia

In a patient with an adrenal mass and hyponatremia discovered on chest CT, immediately perform comprehensive hormonal evaluation including 1-mg dexamethasone suppression test, plasma/urinary metanephrines, and assess for adrenal insufficiency, as hyponatremia may indicate either SIADH from underlying malignancy (particularly small cell lung cancer), autonomous cortisol secretion, or adrenal insufficiency—all of which dramatically alter management and prognosis 1, 2.

Critical Initial Assessment

The combination of adrenal mass and hyponatremia represents a diagnostic emergency requiring urgent evaluation for:

1. Underlying Malignancy Assessment

• Chest CT findings are crucial: 10-45% of small cell lung cancers produce ADH causing SIADH, while only 1% of other lung cancers do so 2
• Adrenal masses may represent metastases (0-21% of incidentalomas) or primary adrenocortical carcinoma (1.2-12%) 1
• If extra-adrenal malignancy is suspected, adrenal biopsy may be considered only after excluding pheochromocytoma 1

2. Mandatory Hormonal Work-up

All patients require screening for:

• Autonomous cortisol secretion: 1-mg dexamethasone suppression test (cortisol >50 nmol/L or >1.8 µg/dL indicates mild autonomous cortisol secretion) 1
• Pheochromocytoma: Plasma or 24-hour urinary metanephrines for any mass >10 HU or with symptoms 1
• Primary aldosteronism: Aldosterone-to-renin ratio if hypertension or hypokalemia present 1
• Adrenal insufficiency: Critical consideration, as bilateral adrenal involvement can cause hyponatremia even with normal basal cortisol 3

3. Hyponatremia Etiology Determination

The hyponatremia requires immediate characterization:

SIADH criteria (most common with lung cancer):

• Serum sodium <134 mEq/L
• Plasma osmolality <275 mosm/kg
• Urine osmolality >500 mosm/kg (inappropriately high)
• Urinary sodium >20 mEq/L
• Exclude hypothyroidism, adrenal insufficiency, volume depletion 2

Critical caveat: Even if SIADH criteria are met, adrenal insufficiency must still be excluded, particularly with bilateral adrenal masses. Case reports demonstrate that hyponatremia can normalize with hydrocortisone despite normal basal cortisol and apparent SIADH 3. This represents a dangerous diagnostic pitfall.

Imaging Protocol

First-Line: Non-Contrast CT

• Measure Hounsfield units (HU)
• HU ≤10: Benign lipid-rich adenoma, no further imaging needed regardless of size 1, 4
• HU >10: Requires second-line imaging

Second-Line Options

• Washout CT or chemical shift MRI for indeterminate masses 1
• Important limitation: ~33% of pheochromocytomas may washout like adenomas, and ~33% of adenomas don't washout appropriately 1

Management Algorithm

If Malignancy Suspected (HU >20, inhomogeneous, >4 cm):

• Multidisciplinary review by endocrinology, surgery, radiology 1
• Repeat functional work-up before any intervention 1
• Consider surgical resection based on size, imaging characteristics, and hormonal status 1

If Functional Adenoma Identified:

• Pheochromocytoma or aldosterone-secreting adenoma: Adrenalectomy indicated, preferably minimally invasive 1
• Cortisol-secreting with Cushing's syndrome: Unilateral adrenalectomy 1
• Mild autonomous cortisol secretion (MACS): Consider surgery if progressive metabolic comorbidities present 1

If Bilateral Adrenal Involvement:

• Measure 17-hydroxyprogesterone to exclude congenital adrenal hyperplasia 1
• Assess for adrenal insufficiency in suspected infiltrative disease, metastases, or hemorrhage 1
• Empiric hydrocortisone should be strongly considered if severe hyponatremia present, even with normal basal cortisol 3

If Benign Non-Functional <4 cm:

• No further follow-up needed 1

If Benign Non-Functional ≥4 cm:

• Repeat imaging in 6-12 months 1
• Surgery if growth >5 mm/year 1

Hyponatremia Management

Severe symptomatic hyponatremia (<120 mEq/L):

• Hypertonic 3% saline IV for life-threatening cases 2
• Correct cautiously to avoid osmotic demyelination 5

Mild SIADH:

• Free water restriction (<1 L/day) as first-line 2
• Vasopressin-2 receptor antagonists (tolvaptan, conivaptan) as adjuncts 2

If adrenal insufficiency suspected:

• Hydrocortisone replacement may normalize sodium even when SIADH criteria are met 3

Critical Pitfalls to Avoid

1. Never biopsy before excluding pheochromocytoma—risk of hypertensive crisis 1
2. Don't assume SIADH without excluding adrenal insufficiency, especially with bilateral masses 3
3. Don't rely solely on basal cortisol—may be falsely reassuring in bilateral adrenal disease 3
4. Don't skip hormonal work-up even if imaging suggests benign adenoma—lipid-poor adenomas overlap with pheochromocytomas 1
5. Avoid routine biopsy of suspected adrenocortical carcinoma—risk of tumor seeding 1